Transient Transfection of Short Hairpin RNA Targeting Epidermal Growth Factor Receptor into Lung Adenocarcinoma A549 Cell Line and Its Effect on Cell Growth and Sensitivity to Cytotoxic Drugs
BAI Li,YU Zu-bin,ZHU Rong,Zhang Xin,GAO Lei,BAI Chun-xue
DOI: https://doi.org/10.3969/j.issn.1007-3639.2007.11.002
2007-01-01
Abstract:Background and purpose:Up-regulation of expression and activation of epidermal growth factor receptor(EGFR)in non-small cell lung carcinoma(NSCLC)is associated with advanced tumor stage,and resistance to radiochemotherapy.EGFR has been identified as an important target in anticancer therapy by blocking EGFR function with the detailed understanding of the biology of EGFR protein and its downstream signal pathway.In this study,we investigated the effects of short hairpin RNA(shRNA)targeting EGFR on cell growth and its sensitivity to cytotoxic drugs in lung adenocarcinoma A549 cell line.Methods:Recombined plasmids of short hairpin RNA targeting EGFR(pShEGFR)and of negative control shRNA(pShNEG)were respectively transfected into A549 cells,and named A549/pShEGFR,A549/pShNEG,and control cell group A549.The protein level of EGFR was observed by immunofluorescence,and then further quantified by Western blot.The effect of shRNA targeting EGFR on tumor cell growth was assessed by colony formation assay,cell cycle and apoptosis by flow cytometry,and the sensitivity of A549 to cytotoxic drugs by 3-4,5-dimethylthiozol-2yl-2,5-diphenyltetrazolium bromide MTT assay.Results:A549/pShEGFR significantly down-regulated EGFR expression by 74.1% on day 6 after transfection and the colony number by 62.8% in A549(P0.01).Compared with the other two groups,A549/pShEGFR caused G1 arrest(63.2±1.1,64.5±1.4 vs.74.2±0.8;P0.01),induced apoptosis(5.8±1.4,7.7±1.2 vs.25.6±1.2;P0.01),and subsequently increased the sensitivity to cisplatin,doxorubicin and paclitaxel by 6.7,5.5,6.6 fold when compared with recombined plasmid A549 respectively(P0.01).Conclusions:Our data suggested that shRNA could effectively inhibit the growth and enhance the sensitivity of A549 cells to different cytotoxic drugs by downregulating the expression of EGFR gene.